Skip to Content

Join the 'Familial Adenomatous Polyposis' group to help and get support from people like you.

Familial Adenomatous Polyposis News

Omega-3s in Fish Tied to Better Colon Cancer Outcomes

Posted 21 Jul 2016 by Drugs.com

THURSDAY, July 21, 2016 – Colon cancer patients who take in higher amounts of omega-3 fatty acids, mainly from oily fish, may have better odds of survival, a new study finds. The study of almost 1,700 American adults with colon cancer was observational, meaning that it can't prove cause-and-effect. But it did seem to find a benefit from the healthy nutrient. One colon cancer expert who reviewed the new findings wasn't surprised. "We have long suspected the health benefits of omega-3 fatty acid supplementation," said Dr. Jules Garbus, a colorectal surgeon at Winthrop-University Hospital in Mineola, N.Y. "This study begins to show a correlation between 'healthy living' and reducing death from colorectal cancer." In the study, a team led by Dr. Andrew Chan, of Massachusetts General Hospital in Boston, tracked data on 1,659 people diagnosed with colon cancer. During an average follow-up of ... Read more

Related support groups: Dietary Supplementation, Fish Oil, Lovaza, Colorectal Cancer, Omega-3, Omacor, MaxEPA, Omega-3 Polyunsaturated Fatty Acids, EPA Fish Oil, Omega 3-6-9 Complex, Restora, Animi-3, Familial Adenomatous Polyposis, Marine Lipid Concentrate, Super-EPA, MegaKrill, Mi-Omega, TherOmega, Omega Essentials, Omega-500

Regular Doctor Visits Can Help Spot Colon Cancer

Posted 5 Jul 2016 by Drugs.com

MONDAY, July 4, 2016 – Making regular visits to a primary care doctor increases the odds you'll be screened for colon cancer, a new study says. Colon cancer is the third most common cancer and the second leading cause of cancer death in the United States. But colon cancer screening is underused, the study authors said. "These findings help underscore the continued importance and effectiveness of visits with primary care physicians in a brave new world of virtual care and population health outreach," said study co-author Dr. Ethan Halm. He is director of the UT Southwestern Center for Patient-Centered Outcomes Research in Dallas. The study researchers analyzed data from more than 968,000 Americans, aged 50 to 74, in four health systems across the country. Those who saw a primary care doctor at least once a year were twice as likely to be screened for colon cancer. And they were 30 ... Read more

Related support groups: Colonoscopy, Colorectal Cancer, Familial Adenomatous Polyposis

Five New Genes Linked to Colon Cancer

Posted 24 Jun 2016 by Drugs.com

FRIDAY, June 24, 2016 – Scientists have identified five new gene mutations that may be tied to colon cancer. The findings are from an analysis of genes from more than 1,000 people with colon cancer. The links between these five gene mutations were very rare, so further research is needed to confirm if they're actually associated with colon cancer. The study authors also concluded that all the major genes that significantly increase the risk of colon cancer have been identified. "Our study is the largest ever conducted of the genetics of bowel [colon] cancer, and sets out a detailed map of the disease that could lead us to new ways of treating or preventing it," study leader Richard Houlston, a professor of molecular and population genetics at the Institute of Cancer Research in London, said in an institute news release. "The research closes one chapter in the study of bowel cancer, by ... Read more

Related support groups: Cancer, Colonoscopy, Colorectal Cancer, Diagnosis and Investigation, Familial Adenomatous Polyposis

Expert Panel Reaffirms Need for Colon Cancer Screen Beginning at Age 50

Posted 15 Jun 2016 by Drugs.com

WEDNESDAY, June 15, 2016 – Reiterating a recommendation last made in 2008, an influential U.S. panel of health experts is advocating that regular colon cancer screening begin at age 50 and continue until at least age 75. However, the U.S. Preventive Services Task Force stopped short of saying any one screening method was better than another. "There are multiple screening options for colorectal cancer that reduce the risk of dying from the disease. We encourage people to choose the best option for them, in consultation with their clinician," former Task Force member Dr. Douglas Owens said Wednesday in a USPSTF news release. The panel's reticence to choose one option over another may be at odds with the preference of many doctors, who often advise colonoscopy as the "gold standard" test. Dr. Arun Swaminath is one of them. "There is only one test – colonoscopy – that can both diagnose a ... Read more

Related support groups: Cancer, Colonoscopy, Colorectal Cancer, Diagnosis and Investigation, Familial Adenomatous Polyposis

Colon Cancer Rising in People Under 50

Posted 24 May 2016 by Drugs.com

TUESDAY, May 24, 2016 – Although overall colon cancer rates are declining, the rates among Americans under 50 have jumped more than 11 percent in the past decade, a new study finds. Over the same decade, the number of cancers in those 50 and older fell by nearly 3 percent, the study found. "Our findings suggest that health care providers should be more vigilant about detecting symptoms in younger patients and also should consider lowering the threshold for colonoscopy screening," lead researcher Dr. Elie Sutton said during a media briefing. Sutton is a research fellow at Mount Sinai West Hospital in New York City. "We really don't know why colon cancer is increasing in younger patients," he said. "We can speculate that it's due to increases in inflammatory bowel disease or a change in diet, but really there is no clear consensus on that." The researchers also found that colon cancer ... Read more

Related support groups: Colonoscopy, Dietary Supplementation, Vitamin/Mineral Supplementation and Deficiency, Colorectal Cancer, Dietary Fiber Supplementation, Familial Adenomatous Polyposis

A Little Excess Weight May Boost Colon Cancer Survival

Posted 20 May 2016 by Drugs.com

THURSDAY, May 19, 2016 – In what may come as a bit of a surprise, a new study found that overweight colon cancer patients tended to have better survival than their normal-weight peers. "Overweight and obesity have been identified as risk factors for many health conditions, but for people with colorectal cancer, some extra weight may provide protection against mortality," said study lead author Candyce Kroenke. She's a research scientist at Kaiser Permanente Division of Research in Oakland, Calif. Still, one health expert cautioned that the finding is no license for people to pile on excess pounds. "This study should not be used to describe an 'upside' of being overweight with regard to cancer risk, since overweight people develop cancer at higher rates," said gastroenterologist Dr. Arun Swaminath of Lenox Hill Hospital in New York City. In the study, Kroenke's team examined the medical ... Read more

Related support groups: Obesity, Weight Loss, Colorectal Cancer, Familial Adenomatous Polyposis

Tumor Location Affects Colon Cancer Survival: Study

Posted 19 May 2016 by Drugs.com

WEDNESDAY, May 18, 2016 – Your survival odds against colon cancer may depend on which side of your colon the tumor develops, new research contends. In a study of more than 1,000 men and women with colon cancer that had spread, those whose tumor was on the left side survived just over 33 months, while those whose tumor was on the right side survived only slightly more than 19 months. "It's a stunning and surprising finding, and the difference is dramatic," said lead researcher Dr. Alan Venook, a professor of medicine at the University of California, San Francisco. It appears that colon cancer that begins on the right side is different from colon cancer that begins on the left side, he said. "We thought of the colon as a tube that propelled stool out of the body, but it's not that simple," Venook said. "Each side of the colon starts in a different place, which is why the cancers are ... Read more

Related support groups: Colonoscopy, Colorectal Cancer, Avastin, Erbitux, Bevacizumab, Cetuximab, Familial Adenomatous Polyposis

Small Study Supports New Stool-Based Colon Cancer Test

Posted 19 Apr 2016 by Drugs.com

TUESDAY, April 19, 2016 – A new, but small, study finds more evidence that a recently approved, stool-based colon cancer test may be effective for certain patients. Still, experts who looked at the findings stressed that the test, called Cologuard, should never be used as a substitute for the "gold standard" colon cancer test, colonoscopy. Cologuard is a noninvasive stool DNA test that detects red blood cells and certain DNA mutations that are associated with colon cancer. The test was approved by the U.S. Food and Drug Administration in 2014. The new study included nearly 400 people at average risk for colon cancer, meaning they had no symptoms and no personal or family history of the disease or precancerous polyps. The patients had also not yet undergone more invasive screening procedures, such as colonoscopy. At one year of follow-up, 51 of the patients (about 15 percent) had a ... Read more

Related support groups: Colonoscopy, Colorectal Cancer, Diagnosis and Investigation, Familial Adenomatous Polyposis

Study Finds Stool Test Effective for Detecting Colon Cancer

Posted 26 Jan 2016 by Drugs.com

MONDAY, Jan. 25, 2016 – Tests for blood in the stool can consistently detect colon cancer when used on an annual basis, and they are effective even in the second, third and fourth years of screening, a new study says. The researchers said these findings suggest that the stool test could be a reasonable screening alternative to colonoscopy – currently considered the gold standard for colon cancer screening. Known as fecal immunochemical tests, experts examine stool samples for microscopic amounts of blood shed by colon tumors, explained study co-author Dr. Douglas Corley, a research scientist with Kaiser Permanente in Oakland, Calif. Doctors have been concerned that fecal blood tests might become less effective over time, hampering their usefulness as a screening tool, he said. Colon tumors or precancerous polyps have to be large to start releasing blood into a person's stool, Corley ... Read more

Related support groups: Cancer, Colonoscopy, Colorectal Cancer, Familial Adenomatous Polyposis

More People Under 50 Getting Colon Cancer, Analysis Finds

Posted 25 Jan 2016 by Drugs.com

MONDAY, Jan. 25, 2016 – Colon cancer rates are rising among men and women under 50, the age at which guidelines recommend screenings start, a new analysis shows. One in seven colon cancer patients is under 50. Younger patients are more likely to have advanced stage cancer, but they live slightly longer without a cancer recurrence because they are treated aggressively, the researchers reported. "Colon cancer has traditionally been thought of as a disease of the elderly," said study lead author Dr. Samantha Hendren, an associate professor of surgery at the University of Michigan in Ann Arbor. "This study is really a wake-up call to the medical community that a relatively large number of colon cancers are occurring in people under 50," she added. However, Hendren said it's too soon to say whether colon cancer screening guidelines should be altered to reflect that trend. In the analysis, ... Read more

Related support groups: Colonoscopy, Hemorrhoids, Colorectal Cancer, Anal Fissure and Fistula, Diagnosis and Investigation, Familial Adenomatous Polyposis, Body Imaging

Vitamin D, Calcium May Not Prevent Colon Cancer After All

Posted 14 Oct 2015 by Drugs.com

WEDNESDAY, Oct. 14, 2015 – New clinical trial results negate the supposed colon cancer-preventing benefits of calcium and vitamin D supplements. Neither calcium nor vitamin D, taken alone or together after precancerous colon polyps were removed, significantly reduced the risk of new polyps developing, researchers report. The results contradict decades of observational studies that showed that people who take lots of calcium and vitamin D are less likely to develop colon cancer, researchers said in the Oct. 15 issue of the New England Journal of Medicine. "It suggests that you should not think you should take calcium or vitamin D to reduce your risk of colon cancer," said study co-author Elizabeth Barry, an assistant professor of epidemiology and community and family medicine at Dartmouth's Geisel School of Medicine in New Hampshire. However, Barry added that this trial focused on a ... Read more

Related support groups: Colonoscopy, Colorectal Cancer, Caltrate 600 with D, Calcium/Vitamin D, Os-Cal 500 with D, Citracal + D, Oysco 500 with D, Citracal Creamy Bites, Calcet, Calcium 600 D, Calcarb with D, Citracal Petites, Familial Adenomatous Polyposis, Oyster Shell Calcium, O-Cal-D, Oyst-Cal-D, Zingiber, Os-Cal 500 + D, Risacal-D, Oystercal-D

1 in 3 Colon Cancers in Young People Has Genetic Link

Posted 24 Jul 2015 by Drugs.com

FRIDAY, July 24, 2015 – More than a third of colon cancers diagnosed in younger patients are caused by inherited gene mutations, a new study finds. These patients should undergo genetic counseling to determine if their families may be at increased risk, the researchers suggested. Hereditary colon cancers are relatively rare overall, but tend to be more common if diagnosed before age 50, the researchers said. However, their prevalence among teens and young adults has not been well documented, according to the researchers. This study included almost 200 patients, aged 35 and younger, who were diagnosed with colon cancer and underwent genetic testing between 2009 and 2013. "We were very surprised to find that 35 percent of that population of patients had a genetic disease, although we hypothesized the proportion would be higher in this age group relative to the general population," study ... Read more

Related support groups: Colorectal Cancer, Diagnosis and Investigation, Familial Adenomatous Polyposis

U.S. Oncologists Decry High Cost of Cancer Drugs

Posted 23 Jul 2015 by Drugs.com

THURSDAY, July 23, 2015 – Soaring costs for cancer drugs are hurting patient care in the United States, a group of top oncologists claim. "High cancer-drug prices are affecting the care of patients with cancer and our health care system," Dr. Ayalew Tefferi, a hematologist at Mayo Clinic in Rochester, Minn., said in a Mayo news release. Tefferi and his colleagues made a number of recommendations on how to address the problem in a commentary published July 23 in the Mayo Clinic Proceedings. Allowing Medicare to negotiate drug prices is one of the suggestions the team of 118 leading cancer experts offered as a possible solution. Along with their recommendations, the group also expressed support for a patient-based grassroots movement on change.org that is demanding action on the issue. "The average gross household income in the U.S. is about $52,000 per year. For an insured patient with ... Read more

Related support groups: Cancer, Provera, Depo-Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Prostate Cancer, Tamoxifen, Medroxyprogesterone, Arimidex, Tretinoin, Femara, Fluorouracil, Lupron Depot, Gleevec, Lung Cancer, Renal Cell Carcinoma, Rituxan, Isotretinoin

The Doctor Who Does Your Colonoscopy Matters

Posted 16 Jun 2015 by Drugs.com

TUESDAY, June 16, 2015 – The doctor performing your colonoscopy makes a difference in whether you'll develop colon cancer or die from it, a new study finds. Colonoscopy saves lives, and "high quality" colonoscopies save even more, the study authors said. High quality means screening by doctors adept at identifying many precancerous growths (polyps), they said. "The results further suggest that efforts to improve the detection and removal of precancerous polyps will likely not only help patients, but will support current efforts to improve the quality of the test and be cost-effective," said study lead author Reinier Meester, of Erasmus MC University Medical Center in Rotterdam, the Netherlands. In the study, higher-quality colonoscopies were associated with a 50 to 60 percent lower risk for colon cancer and colon cancer fatalities over a patient's lifetime. Higher-quality screenings ... Read more

Related support groups: Colonoscopy, Colorectal Cancer, Diagnosis and Investigation, Familial Adenomatous Polyposis

New Colon Polyp Removal Method May Be Easier on Patients

Posted 6 May 2014 by Drugs.com

MONDAY, May 5, 2014 – A team-based procedure for removing difficult or large precancerous colon polyps is effective and eliminates the need to take out part of a person's colon to reduce their cancer risk, a small clinical trial shows. In the procedure, a surgeon manipulates the colon from outside the organ so that a second doctor can get to the hard-to-reach polyp and remove it from inside the colon via colonoscopy. This team procedure, called "laparoscopic-assisted colonoscopy with polypectomy," eliminates the need for a surgeon to remove the entire section of the colon that contains the polyp, a procedure called "laparoscopic hemicolectomy." A clinical trial comparing the new and old procedures found that laparoscopic-assisted colonoscopy is as safe and effective as surgery to remove part of the colon, but results in shorter hospital stays and less harm done to patients, said lead ... Read more

Related support groups: Familial Adenomatous Polyposis

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Colorectal Cancer

Related Drug Support Groups

Celebrex, sulindac, celecoxib, Clinoril